ELOVL5 and fatty liver disease: Ablation of Elovl5 revealed a relationship between AA and DHA deficiency in liver and upregulation of lipogenesis via an SREBP-1c-dependent pathway that eventually caused hepatic steatosis in the Elovl5−/− mice.